Autres langues REYON Pharmaceutical Co., Ltd.

Actions

A102460

KR7102460003

Cours en clôture Korea S.E. Autres places de cotation 00:00:00 10/05/2024			Varia. 5j.	Varia. 1 janv.
14 590 ^KRW	+2,75 %		+5,27 %	-11,79 %

21/03	REYON Pharmaceutical Co. annonce ses résultats pour l'exercice clos le 31 décembre 2023	CI
2023	REYON Pharmaceutical Co. annonce ses résultats pour le troisième trimestre et les neuf mois clos le 30 septembre 2023	CI

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

REYON Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	21/03
REYON Pharmaceutical Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	14/11
REYON Pharmaceutical Co., Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	14/08/23
REYON Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	15/05/23
REYON Pharmaceutical Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	15/11/22
REYON Pharmaceutical Co., Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	16/08/22
REYON Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022	16/05/22
REYON Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021	22/03/22
REYON Pharmaceutical Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	15/11/21
REYON Pharmaceutical Co., Ltd. announced that it has received KRW 10 billion in funding	26/07/21
REYON Pharmaceutical Co., Ltd. announced that it expects to receive KRW 10 billion in funding	14/05/21
MÄRKTE ASIEN/Wenig veränderte Börsen mit positiver Tendenz	20/11/20
Tranche Update on REYON Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on July 6, 2018.	07/01/19
REYON Pharmaceutical Co., Ltd.'s Equity Buyback announced on July 6, 2018 has expired with 240,840 shares, representing 1.44% for KRW 4,975.65 million.	05/01/19
Tranche Update on REYON Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on July 6, 2018.	10/10/18
REYON Pharmaceutical Co., Ltd. announces an Equity Buyback for KRW 5,000 million worth of its shares.	06/07/18
REYON Pharmaceutical Co., Ltd. authorizes a Buyback Plan.	06/07/18
REYON Pharmaceutical Co., Ltd. announced that it has received KRW 40 billion in funding from Mirae Asset Daewoo Co., Ltd., KDB Capital Corp., Eum Private Equity, Industrial Bank of Korea, Investment Arm	21/07/17
REYON Pharmaceutical Co., Ltd. announced that it expects to receive KRW 40 billion in funding from Mirae Asset Daewoo Co., Ltd., KDB Capital Corp., Eum Private Equity, Industrial Bank of Korea, Investment Arm	20/07/17
REYON Pharmaceutical Co., Ltd.(KOSE:A102460) added to MSCI Acwi + Frontier Markets(acwi Fm) All Cap Index	01/12/15

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues REYON Pharmaceutical Co., Ltd.

Actions

A102460

KR7102460003

Autres langues

Filtres